Singtel stock (Z74.SI) slips at Friday close — what Singapore investors watch next

Singtel stock (Z74.SI) slips at Friday close — what Singapore investors watch next

SINGAPORE, Jan 10, 2026, 14:55 SGT — Market closed

  • Singapore Telecommunications (Singtel) ended Friday down 0.22% at S$4.46 after a choppy week.
  • The Straits Times Index rose 0.1% on Friday as traders tracked global risk cues and U.S. tariff headlines.
  • Next catalysts include U.S. CPI on Jan 13 and Singtel’s next earnings date listed for Feb 18.

Singapore Telecommunications Ltd (Singtel) shares eased 0.22% on Friday to end at S$4.46, after trading between S$4.45 and S$4.49. The stock is up about 45% over the past year, within a 52-week range of S$3.07 to S$4.92, according to market data. (Source: Investing)

The Singapore market is shut for the weekend, and investors now head into Monday with the benchmark Straits Times Index up 0.1% on Friday to 4,744.66. Traders also watched U.S. tariff headlines; “Tariffs are not going anywhere,” Neil Wilson, UK investment strategist at Saxo Markets, said. (Source: The Straits Times)

Overnight, Wall Street hit record highs after U.S. payrolls rose by 50,000 in December, below the 60,000 expected in a Reuters poll, keeping rate-cut expectations broadly intact. “Payrolls were a little bit light relative to consensus, but still fairly strong numbers,” Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder, said. (Source: Reuters)

In Singapore, the Monetary Authority of Singapore launched a consultation on securities-law changes meant to smooth dual listings on SGX and Nasdaq and allow U.S.-style “safe harbour” share buybacks — legal protection for repurchases done under set conditions. MAS said the package would support a planned Global Listing Board on SGX. (Source: Reuters)

For Singtel, the near-term tape is tight. Thursday’s low at S$4.40 is the first chart point traders talk about, while S$4.49 has capped the last two sessions.

The company last gave a full set of updates in November, when it posted a 14% rise in first-half underlying profit — which strips out some one-offs — and lifted its forecast for operating-company earnings before interest and tax (EBIT) growth in fiscal 2026 to between high single digits and low double digits. Chief executive Yuen Kuan Moon said its “growth engines” should “change the complexion” of the business as they scale. (Source: Reuters)

Buybacks also sit in the background. Singtel announced a S$2 billion share repurchase plan in May 2025 and raised its medium-term asset recycling target to S$9 billion after selling a small Bharti Airtel stake; Citi analysts said then the buyback came earlier than expected. (Source: Reuters)

But the downside case is familiar: outages, regulatory scrutiny and execution risk can drag on sentiment even in “defensive” telecom names. Singtel was fined S$1 million in December by Singapore regulator IMDA over a fixed-line voice outage that disrupted calls to emergency hotlines, and the company said it accepted the penalty. (Source: The Straits Times)

When trading resumes on Monday, investors will be watching U.S. consumer price data due on Jan 13 and the next set of U.S. Supreme Court rulings on tariffs expected on Jan 14. Earnings calendars tracked by Investing.com list Singtel’s next report for Feb 18. (Sources: BLS, Investing)

Stock Market Today

  • Vera Therapeutics Valuation Under Scrutiny After Momentum
    January 10, 2026, 5:06 PM EST. Vera Therapeutics (VERA) trades at $48.71 after a sharp rally, with a 1-month gain near 9.9% and a 3-month advance around 61.9% as investors weigh growth against clinical and financing risks. The 3-year total shareholder return runs about 7x. On a P/B of 8.7x, the stock sits above the broader US biotech average (2.7x) but below some peers (11.8x). A DCF view yields a fair value about $242.41, implying roughly an 80% discount to the current price. The company reports no revenue and a net loss of about $251.9 million. Upside depends on trial progress and funding; downside risk remains if milestones slip or financing deteriorates. Analysts' targets are higher than today's price, keeping a watchful eye on progress.
UOB stock ends flat near S$36 after fresh buyback; traders eye Jan 14 tariff ruling
Previous Story

UOB stock ends flat near S$36 after fresh buyback; traders eye Jan 14 tariff ruling

CapitaLand Investment (SGX:9CI) stock ends week higher — what to watch before Feb 11 results
Next Story

CapitaLand Investment (SGX:9CI) stock ends week higher — what to watch before Feb 11 results

Go toTop